Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma

Joanne E. Kavanagh; Andrew P. Hearn; Grainne d’Ancona; Jaideep Dhariwal; Cris Roxas; Linda Green; Louise Thomson; Mariana Fernandes; Brian D. Kent; Alexandra M. Nanzer; David J. Jackson

doi:10.1111/all.14693

Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma

Joanne E. Kavanagh, Andrew P. Hearn, Grainne d’Ancona, Jaideep Dhariwal, Cris Roxas, Linda Green, Louise Thomson, Mariana Fernandes, Brian D. Kent, Alexandra M. Nanzer, David J. Jackson^*

^*Corresponding author for this work

Peter Gorer Department of Immunobiology

Research output: Contribution to journal › Letter › peer-review

41 Citations (Scopus)

Original language	English
Journal	Allergy: European Journal of Allergy and Clinical Immunology
DOIs	https://doi.org/10.1111/all.14693
Publication status	Accepted/In press - 2020

Access to Document

10.1111/all.14693

Cite this

@article{62c7cd46bcd942a8aceb073fed9f3cd5,

title = "Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma",

author = "Kavanagh, {Joanne E.} and Hearn, {Andrew P.} and Grainne d{\textquoteright}Ancona and Jaideep Dhariwal and Cris Roxas and Linda Green and Louise Thomson and Mariana Fernandes and Kent, {Brian D.} and Nanzer, {Alexandra M.} and Jackson, {David J.}",

year = "2020",

doi = "10.1111/all.14693",

language = "English",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "John Wiley and sons",

}

TY - JOUR

T1 - Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma

AU - Kavanagh, Joanne E.

AU - Hearn, Andrew P.

AU - d’Ancona, Grainne

AU - Dhariwal, Jaideep

AU - Roxas, Cris

AU - Green, Linda

AU - Thomson, Louise

AU - Fernandes, Mariana

AU - Kent, Brian D.

AU - Nanzer, Alexandra M.

AU - Jackson, David J.

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85099499352&partnerID=8YFLogxK

U2 - 10.1111/all.14693

DO - 10.1111/all.14693

M3 - Letter

C2 - 33300186

AN - SCOPUS:85099499352

SN - 0105-4538

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

ER -

Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma

Access to Document

Other files and links

Cite this